EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases

Pavel V Chernyshov iD, Andrew Y Finlay iD, Aikaterini Patsatsi iD, Branka Marinović iD, Carmen Salavastru iD, Dedee F Murrell iD, Lucia Tomas-Aragones iD, Francoise Poot iD, Nives Pustisek iD, Ake Svensson iD, Servando E Marron iD, Francesca Sampogna iD und 11 weitere

International Journal of Dermatology · 2026

DOI: 10.1111/ijd.17964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2026. Verfasst von Pavel V Chernyshov und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine. Hauptthemen laut MEDLINE: Quality of Life, Autoimmune Diseases, Skin Diseases, Vesiculobullous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient Oriented Outcomes and on Autoimmune Bullous Diseases (AIBD) collaborated on a position statement regarding the QoL instruments that could better evaluate the health‐related (HR)QoL in different phases of the course of these chronic diseases. Position statements were formed and accepted by voting of all authors. The ability to use a measure that has a validated system to interpret scores and has a known minimal clinical important difference (MCID), such as the Dermatology Life Quality Index (DLQI), is an important aspect when choosing which HRQoL instrument to use. The EADV TFs encourage the use of the DLQI as a dermatology‐specific instrument and Autoimmune Bullous Disease Quality of Life (ABQOL) and Treatment of Autoimmune Bullous Disease Quality of Life (TABQOL) as AIBD‐specific instruments for HRQoL assessment in AIBDs. The EADV TFs encourage the use of the oral health‐specific instruments Oral Health Impact Profile‐14 (OHIP‐14) or Chronic Oral Mucosal Disease Questionnaire (COMDQ) in AIBD patients with severe oral involvement. OHIP‐14 has fewer items and that may influence the choice for practical use. The EADV TFs encourage the study, where appropriate, of family QoL of AIBD patients by using dermatology‐specific family QoL instruments, such as the Family Dermatology Life Quality Index (FDLQI) or general measures such as the Family Reported Outcome Measure (FROM‐16). The EADV TFs recommend that HRQoL instruments be used in randomized controlled studies of new therapeutic approaches. The EADV TFs encourage researchers and clinicians to validate and use HRQoL instruments in patients with AIBDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeAutoimmune DiseasesSkin Diseases, VesiculobullousHumansDermatologyEuropeVenereologySurveys and Questionnaires

Stichwörter der Autor:innen

autoimmune blistering diseasebullous pemphigoidmeasurementmucous membrane pemphigoidpemphigusquality of life

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine.
  • Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Center of Expertise on AIBD, 2nd Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece.
  • University Department of Dermatology and Venereology, School of Medicine, University of Zagreb, Clinical University Hospital Center Zagreb, Zagreb, Croatia.
  • Department of Paediatric Dermatology, Colentina Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
  • Faculty of Medicine, University of New South Wales, St George Campus, Sydney, Australia.

ORCID-Profile: Pavel V Chernyshov, Andrew Y Finlay, Aikaterini Patsatsi, Branka Marinović, Carmen Salavastru, Dedee F Murrell, Lucia Tomas-Aragones, Francoise Poot, Nives Pustisek, Ake Svensson, Servando E Marron, Francesca Sampogna, Anthony Bewley, Dimitra Koumaki, Alina Suru, Damiano Abeni, Sam S Salek, Stamatios Gregoriou, Emiliano Antiga, Victoria P Werth, Matthias Augustin, Jacek C Szepietowski, Enno Schmidt

Zitieren

APA

Chernyshov, P. V., Finlay, A. Y., Patsatsi, A., Marinović, B., Salavastru, C., Murrell, D. F., Tomas-Aragones, L., Poot, F., Pustisek, N., Svensson, A., Marron, S. E., Sampogna, F., Bewley, A., Koumaki, D., Suru, A., Abeni, D., Salek, S. S., Gregoriou, S., Antiga, E., …, & Schmidt, E. (2026). Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases. International Journal of Dermatology. https://doi.org/10.1111/ijd.17964

Vancouver

Chernyshov PV, Finlay AY, Patsatsi A, Marinović B, Salavastru C, Murrell DF, et al. Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases. International Journal of Dermatology. 2026. doi:10.1111/ijd.17964

BibTeX
@article{Chernyshov2026,
  author = {Chernyshov, Pavel V and Finlay, Andrew Y and Patsatsi, Aikaterini and Marinović, Branka and Salavastru, Carmen and Murrell, Dedee F and Tomas-Aragones, Lucia and Poot, Francoise and Pustisek, Nives and Svensson, Ake and Marron, Servando E and Sampogna, Francesca and Bewley, Anthony and Koumaki, Dimitra and Suru, Alina and Abeni, Damiano and Salek, Sam S and Gregoriou, Stamatios and Antiga, Emiliano and Werth, Victoria P and Augustin, Matthias and Szepietowski, Jacek C and Schmidt, Enno},
  title = {Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases},
  journal = {International Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ijd.17964}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche